Atara Biotherapeutics, Inc 10-K for FY2023
Atara Biotherapeutics, Inc. (ATRA)
10-K
2024-03-28
For: 2023-12-31
View Original
Added on
April 11, 2026
About this 10-K
Atara Biotherapeutics, Inc filed this 10-K on March 28, 2024, covering the fiscal year ended December 31, 2023 (FY2023).
Headline figures
Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $8.57M
- down 86.5% from $63.57M a year earlier
- Net loss
- $276.13M
- compared with a net loss of $228.3M a year earlier
- Diluted EPS
- -$2.61
- compared with -$2.24 a year earlier